Loading...
XJPX
7061
Market cap84mUSD
Apr 03, Last price  
1,460.00JPY
1D
0.00%
1Q
5.04%
IPO
-32.59%
Name

Japan Hospice Holdings Inc

Chart & Performance

D1W1MN
P/E
19.26
P/S
1.02
EPS
75.82
Div Yield, %
Shrs. gr., 5y
1.64%
Rev. gr., 5y
23.64%
Revenues
12.12b
+22.72%
1,895,428,0003,015,192,0004,193,652,0004,916,896,0006,019,237,0007,894,317,0009,871,866,00012,115,000,000
Net income
639m
-6.29%
-60,490,000149,456,000297,894,000107,060,000240,801,000454,729,000681,880,000639,000,000
CFO
835m
-26.14%
4,667,000240,716,000322,592,000236,194,000467,099,000873,832,0001,130,463,000835,000,000

Profile

Japan Hospice Holdings Inc. engages in hospice housing and home care businesses in Japan. The company offers care services at hospice housing for patients with terminal cancer and intractable diseases; and home-visit nursing services. It also provides home care services, which supports medical care, including physical care and life support, as well as offers day and nursing multi-function home care services. The company was founded in 2017 and is headquartered in Tokyo, Japan.
IPO date
Mar 28, 2019
Employees
778
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
12,115,000
22.72%
9,871,866
25.05%
7,894,317
31.15%
Cost of revenue
10,428,000
8,293,000
6,696,475
Unusual Expense (Income)
NOPBT
1,687,000
1,578,866
1,197,842
NOPBT Margin
13.92%
15.99%
15.17%
Operating Taxes
368,000
346,453
305,581
Tax Rate
21.81%
21.94%
25.51%
NOPAT
1,319,000
1,232,413
892,261
Net income
639,000
-6.29%
681,880
49.95%
454,729
88.84%
Dividends
Dividend yield
Proceeds from repurchase of equity
11,324
21,382
BB yield
-0.06%
-0.10%
Debt
Debt current
1,603,000
600,155
643,390
Long-term debt
20,244,000
18,330,163
13,099,976
Deferred revenue
Other long-term liabilities
293,000
289,889
278,798
Net debt
19,421,000
17,020,604
11,612,342
Cash flow
Cash from operating activities
835,000
1,130,463
873,832
CAPEX
(3,083,000)
(1,982,000)
(533,069)
Cash from investing activities
(2,791,000)
(1,011,935)
48,270
Cash from financing activities
1,598,000
256,454
(448,156)
FCF
(1,795,175)
(1,956,512)
(477,195)
Balance
Cash
1,526,000
1,884,006
1,509,024
Long term investments
900,000
25,708
622,000
Excess cash
1,820,250
1,416,121
1,736,308
Stockholders' equity
2,662,000
1,968,334
1,306,901
Invested Capital
15,103,750
12,458,895
8,900,196
ROIC
9.57%
11.54%
10.94%
ROCE
9.97%
11.38%
11.74%
EV
Common stock shares outstanding
8,394
8,092
8,081
Price
1,390.00
-38.60%
2,264.00
-12.38%
2,584.00
11.91%
Market cap
11,667,718
-36.31%
18,320,585
-12.26%
20,880,234
12.09%
EV
31,088,718
35,341,189
32,518,773
EBITDA
2,218,000
1,990,608
1,534,606
EV/EBITDA
14.02
17.75
21.19
Interest
350,586
282,892
Interest/NOPBT
22.20%
23.62%